Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Jacobs

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Cancer|March 1, 1986
Short-term persistence of carcinoma of the uterine cervix after radiation. An indicator of long-term prognosisA J Jacobs, C Faris, C A Perez, et al.
Cancer|November 1, 1986
Carcinoma of the fallopian tube. Management and sites of failureE H McMurray, A J Jacobs, C A Perez, et al.
Cancer|March 1, 1988
Serum copper in ovarian carcinomaA J Jacobs, G M Sommers, J H Axelrod, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 1, 1997
Recovery of neurofilament expression selectively in regenerating reticulospinal neuronsA J Jacobs, G P Swain, J A Snedeker, et al.
American Journal of Clinical Oncology|October 1, 1986
Treatment of carcinoma of the fallopian tube using cisplatin, doxorubicin, and cyclophosphamideA J Jacobs, E H McMurray, J Parham, et al.
Obstetrics and Gynecology|October 1, 1993
A phase I trial of a rhenium 186-labeled monoclonal antibody administered intraperitoneally in ovarian carcinoma: toxicity and clinical responseA J Jacobs, M Fer, F M Su, et al.
British Journal of Cancer|July 17, 1999
Pharmacodynamics of cisplatin in human head and neck cancer: correlation between platinum content, DNA adduct levels and drug sensitivity in vitro and in vivoM J Welters, A M Fichtinger-Schepman, R A Baan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 1999
The potential of plantinum-DNA adduct determination in ex vivo treated tumor fragments for the prediction of sensitivity to cisplatin chemotherapyM J Welters, B J Braakhuis, A J Jacobs-Bergmans, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 1988
Mini-colpostats in the treatment of carcinoma of the uterine cervixR R Kuske, C A Perez, A J Jacobs, et al.
American Journal of Clinical Oncology|December 1, 1989
Phase I/II study of definitive radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) for advanced or recurrent gynecologic malignancies. Preliminary reportR R Kuske, C A Perez, P W Grigsby, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Cancer|March 1, 1986
Short-term persistence of carcinoma of the uterine cervix after radiation. An indicator of long-term prognosisA J Jacobs, C Faris, C A Perez, et al.
Cancer|November 1, 1986
Carcinoma of the fallopian tube. Management and sites of failureE H McMurray, A J Jacobs, C A Perez, et al.
Cancer|March 1, 1988
Serum copper in ovarian carcinomaA J Jacobs, G M Sommers, J H Axelrod, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 1, 1997
Recovery of neurofilament expression selectively in regenerating reticulospinal neuronsA J Jacobs, G P Swain, J A Snedeker, et al.
American Journal of Clinical Oncology|October 1, 1986
Treatment of carcinoma of the fallopian tube using cisplatin, doxorubicin, and cyclophosphamideA J Jacobs, E H McMurray, J Parham, et al.
Obstetrics and Gynecology|October 1, 1993
A phase I trial of a rhenium 186-labeled monoclonal antibody administered intraperitoneally in ovarian carcinoma: toxicity and clinical responseA J Jacobs, M Fer, F M Su, et al.
British Journal of Cancer|July 17, 1999
Pharmacodynamics of cisplatin in human head and neck cancer: correlation between platinum content, DNA adduct levels and drug sensitivity in vitro and in vivoM J Welters, A M Fichtinger-Schepman, R A Baan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 17, 1999
The potential of plantinum-DNA adduct determination in ex vivo treated tumor fragments for the prediction of sensitivity to cisplatin chemotherapyM J Welters, B J Braakhuis, A J Jacobs-Bergmans, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 1988
Mini-colpostats in the treatment of carcinoma of the uterine cervixR R Kuske, C A Perez, A J Jacobs, et al.
American Journal of Clinical Oncology|December 1, 1989
Phase I/II study of definitive radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) for advanced or recurrent gynecologic malignancies. Preliminary reportR R Kuske, C A Perez, P W Grigsby, et al.
Pageof 8